Objective To assess whether antimüllerian hormone (AMH) is a predictor of implantation
and/or clinical pregnancy in women undergoing assisted reproductive technology. Design …

BACKGROUND Anti-Müllerian hormone (AMH) is an established marker of ovarian reserve
and a good predictor of poor or excessive ovarian response after controlled …

Context: Previous studies have suggested that antimüllerian hormone (AMH) levels are
positively associated with in vitro fertilization (IVF) outcome through their relationship with …

Objective To determine if serum antimüllerian hormone (AMH) is associated with and/or
predictive of live birth assisted reproductive technology (ART) outcomes. Design …

Objective To determine the predictive attributes of antimüllerian hormone (AMH) in terms of
oocyte yield, cycle cancellation, and pregnancy outcomes. Design Retrospective cohort …

Objective To investigate whether serum antimüllerian hormone (AMH) levels are
independently related to miscarriage rates after in vitro fertilization–embryo transfer (IVF-ET) …

STUDY QUESTION Is serum anti-Müllerian hormone (AMH) level predictive of cumulative
live birth (CLB) rate after ART or in women trying to conceive naturally? SUMMARY …

The conflicting results from studies on the predictive capabilities of serum anti-Müllerian
hormone (AMH) for IVF pregnancy outcomes may be attributed to small sample sizes and …

In the present study, we evaluated the clinical value of the following parameters: basal anti-
Müllerian hormone (AMH), follicle-stimulating hormone (FSH), inhibin B and antral follicle …

Context Antimüllerian hormone (AMH) level is strongly associated with ovarian response in
assisted reproductive technology (ART) cycles but is a poor predictor of live birth. It is …